SELLAS Life Sciences SLS
NASDAQ SLS
$11.74 +0.41 (+3.62%)
At close: Oct 2, 2026 · 4:00 PM EDT

SELLAS Life Sciences (SLS) Amortization of Deferred Charges (2021)

Updated

SELLAS Life Sciences (SLS) recorded Amortization of Deferred Charges of $846,000 in Q1 2021.

Analysis

SELLAS Life Sciences (SLS) Amortization of Deferred Charges (2021) Analysis & Trends

For FY2020, SELLAS Life Sciences reported Amortization of Deferred Charges of $300,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 SELLAS Life Sciences 2.37 Bn 2.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 846,000.00
API Access

SELLAS Life Sciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=SLS&period=max&api_key=YOUR_API_KEY